Dragonfly Capital | Sep 13, 2013 01:38AM ET
There were a lot of small cap pharmaceutical companies that showed up on my watchlist this weekend. Most were too small to trade so I made no mention. These often get into my universe of stocks when a subscriber or follower asks about them. They may not be good to trade, but sometimes they are useful to learn from. One of these is Transcept Pharmaceuticals (TSPT). The short term chart below shows that last Friday it closed at 3.02, and more importantly over the 50 day Simple Moving Average (SMA) for the first time since August 6th and only the 3rd time since March 4th. The Relative Strength Index (RSI) was breaking the mid line and the Moving Average Convergence Divergence indicator (MACD) has just crossed positive. The bottom looked to be in and the gap fill above looked like a good target. Fast forward
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.